» Articles » PMID: 24311148

TB and HIV in the Central African Region: Current Knowledge and Knowledge Gaps

Overview
Journal Infection
Date 2013 Dec 7
PMID 24311148
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Reliable and comprehensive data on the HIV/AIDS and TB co-pandemics from Central Africa remain scarce. This systematic review provides a comprehensive overview on current and past research activities in the region and provides a basis for future research work to close knowledge gaps.

Methods: The scientific literature was searched for publications meeting the following search terms: "tuberculosis" or "HIV" or "acquired immunodeficiency syndrome", combined with "Central Africa", or the names of individual countries within the region. Original studies, reviews and case series were included, and a selection of relevant articles was made.

Results: Most research in the field of HIV and TB has been conducted in Cameroon, where the epidemics have been described fairly well. The Democratic Republic of Congo ranked second on the amount of publications, despite the civil wars over the past several decades. Very little has been published on HIV and TB in the other countries, possibly due to the poor infrastructure of health care systems, lack of scientific capacity building or shortage of laboratory equipment.

Conclusions: Despite the relatively high burden of HIV and TB in the Central African region, the amount of research activities on these topics is limited. A better understanding of the co-epidemics in this region is urgently needed. The occurrence of opportunistic infections, treatment complications and drug resistance in TB and HIV need to be better described; the failure of public health systems needs to be understood, and research infrastructure needs to be developed. Only then will it be possible to turn the tide against the HIV and TB epidemics in this region.

Citing Articles

Global, regional, and national burden of HIV and tuberculosis and predictions by Bayesian age-period-cohort analysis: a systematic analysis for the global burden of disease study 2021.

Tian X, Wang C, Hao Z, Chen J, Wu N Front Reprod Health. 2024; 6:1475498.

PMID: 39720120 PMC: 11666487. DOI: 10.3389/frph.2024.1475498.


Long-term trends of tuberculosis incidence and mortality in four central African countries.

Martial N, Mubarik S, Yu C Sci Rep. 2021; 11(1):16624.

PMID: 34404835 PMC: 8371097. DOI: 10.1038/s41598-021-95967-8.


Development of sustainable research excellence with a global perspective on infectious diseases: Centre de Recherches Médicales de Lambaréné (CERMEL), Gabon.

Ramharter M, Agnandji S, Adegnika A, Lell B, Mombo-Ngoma G, Grobusch M Wien Klin Wochenschr. 2021; 133(9-10):500-508.

PMID: 33398458 PMC: 7781170. DOI: 10.1007/s00508-020-01794-8.


Low incidence of the immune reconstitution inflammatory syndrome among HIV-infected patients starting antiretroviral therapy in Gabon: a prospective cohort study.

Janssen S, Osbak K, Holman R, Hermans S, Moekotte A, Knap M Infection. 2017; 45(5):669-676.

PMID: 28349491 PMC: 5630650. DOI: 10.1007/s15010-017-1000-9.


Tuberculosis Treatment Outcome and Drug Resistance in Lambaréné, Gabon: A Prospective Cohort Study.

Belard S, Remppis J, Bootsma S, Janssen S, Kombila D, Beyeme J Am J Trop Med Hyg. 2016; 95(2):472-80.

PMID: 27352879 PMC: 4973203. DOI: 10.4269/ajtmh.15-0668.


References
1.
Sieleunou I, Souleymanou M, Schonenberger A, Menten J, Boelaert M . Determinants of survival in AIDS patients on antiretroviral therapy in a rural centre in the Far-North Province, Cameroon. Trop Med Int Health. 2008; 14(1):36-43. DOI: 10.1111/j.1365-3156.2008.02183.x. View

2.
Marcellin F, Boyer S, Protopopescu C, Dia A, Ongolo-Zogo P, Koulla-Shiro S . Determinants of unplanned antiretroviral treatment interruptions among people living with HIV in Yaoundé, Cameroon (EVAL survey, ANRS 12-116). Trop Med Int Health. 2008; 13(12):1470-8. DOI: 10.1111/j.1365-3156.2008.02170.x. View

3.
Torpey K, Kasonde P, Kabaso M, Weaver M, Bryan G, Mukonka V . Reducing pediatric HIV infection: estimating mother-to-child transmission rates in a program setting in Zambia. J Acquir Immune Defic Syndr. 2010; 54(4):415-22. DOI: 10.1097/QAI.0b013e3181e36616. View

4.
Gandhi N, Moll A, Sturm A, Pawinski R, Govender T, Lalloo U . Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet. 2006; 368(9547):1575-80. DOI: 10.1016/S0140-6736(06)69573-1. View

5.
Caron M, Makuwa M, Souquiere S, Descamps D, Brun-Vezinet F, Kazanji M . Human immunodeficiency virus type 1 seroprevalence and antiretroviral drug resistance-associated mutations in miners in Gabon, central Africa. AIDS Res Hum Retroviruses. 2008; 24(9):1225-8. DOI: 10.1089/aid.2008.0097. View